SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-318424
Filing Date
2021-11-03
Accepted
2021-11-03 16:12:07
Documents
14
Period of Report
2021-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d239863d8k.htm   iXBRL 8-K 28948
2 EX-99.1 d239863dex991.htm EX-99.1 6426
6 GRAPHIC g239863g31a51.jpg GRAPHIC 2728
  Complete submission text file 0001193125-21-318424.txt   169460

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20211031.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20211031_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20211031_pre.xml EX-101.PRE 11853
7 EXTRACTED XBRL INSTANCE DOCUMENT d239863d8k_htm.xml XML 3470
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 211375483
SIC: 2834 Pharmaceutical Preparations